India carbamazepine market is expected to grow at a steady rate during the forecast period. The India carbamazepine market is driven by use of these drugs for the treatment of epilepsy and neuropathic pain. Carbamazepine are found at as chewable tablet, suspension, tablet, extended release tablet, and extended release capsule. In addition to this, upsurge in the demand for carbamazepine for treating numerous types of seizures and bipolar disorders is expected to rev up the market growth through FY2026. Additionally, supportive government policies and improving healthcare infrastructure are some other reasons that are expected to create lucrative opportunities for the market growth over the next few years.
The India carbamazepine market is segmented based on route of administration, source, form, distribution channel, application, end user, company and region. Based on source, the market can be split into in-house and contract manufacturing organizations. Out of which, the in-house segment dominated the market until 2017 owing to in house production preference by the major market players. The contract manufacturing organizations segment is expected to witness significant growth during the forecast period on account of increased outsourcing activities by the major companies in order to focus on their R&D activity and expansion plans. Additionally, contract manufacturing organizations offer competitive pricing and can provide bulk orders in lesser duration.
The major players operating in the India carbamazepine market are Taj Pharmaceuticals Ltd, Jubilant Pharma Ltd., Novartis India Ltd., Abbott India Ltd., Psychotropics India Limited, Anuja Healthcare Limited, Taro Pharmaceuticals India Pvt. Ltd., Teva Pharmaceuticals Industries Ltd., Biomed Pharmaceuticals Pvt. Ltd., Sun Pharmaceuticals Industries Limited and others. Major companies are developing advanced technologies, receiving approvals from regulatory
Years considered for this repor
Historical YearsFY2016-FY2019
Base YearFY2020
Estimated YearFY2021
Forecast PeriodFY2022–FY2026
Objective of the Study
- To analyze and estimate the market size of India carbamazepine market from FY2016 to FY2019.
- To estimate and forecast the market size of India carbamazepine market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India carbamazepine market based on route of administration, source, form, distribution channel, application, end user, company and regional distribution.
- To identify dominant region or segment in the India carbamazepine market.
- To identify drivers and challenges for India carbamazepine market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India carbamazepine market.
- To identify and analyze the profile of leading players operating in India carbamazepine market.
- To identify key sustainable strategies adopted by market players in India carbamazepine market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of
Key Target Audience
- Carbamazepine manufacturers/ suppliers/ distributors
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to carbamazepine
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
